Clinical trial

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

NCT07206121

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-02-10

PhaseNA

Study timeline

Study start (estimated)2026-02-10Date precision: day

Registry last updated2026-02-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Breast-conserving Surgeryunresolved

Breast Cancer - Infiltrating Ductal Carcinomaunresolved

ER/PR+Her2neuunresolved

Grade I, II, IIIunresolved

Interventions

Radiofrequency ablation aloneDEVICE

Radiofrequency ablation Electrosurgical DeviceDEVICE

Sponsors & collaborators

Innoblative Designs, Inc.lead sponsor

Mapped research locations

GalvestonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07206121 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.